Andrew Oxtoby is Chief Commercial Officer of Chinook Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CHINOOK THERAPEUTICS, INC.
2 Mar 23
3
CHINOOK THERAPEUTICS, INC.
16 Feb 23
4
Aimmune Therapeutics, Inc.
14 Oct 20
4
Aimmune Therapeutics, Inc.
16 Sep 20
4
Aimmune Therapeutics, Inc.
12 May 20
4
Aimmune Therapeutics, Inc.
17 Mar 20
4/A
Aimmune Therapeutics, Inc.
4 Mar 20
4
Aimmune Therapeutics, Inc.
4 Mar 20
4
Aimmune Therapeutics, Inc.
3 Mar 20
4
Aimmune Therapeutics, Inc.
24 Jan 19
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Feb 23 | KDNY Chinook Therapeutics | Restricted Stock (RSU)(Common Stock) Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 40,000 |
| 28 Feb 23 | KDNY Chinook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 21.82 | 160,000 | 3.49 mm | 160,000 |